Pharmx Technologies Ltd (AU:PHX) — Market Cap & Net Worth
Market Cap & Net Worth: Pharmx Technologies Ltd (PHX)
Pharmx Technologies Ltd (AU:PHX) has a market capitalization of $36.06 Million (AU$50.96 Million) as of September 17, 2026. Listed on the AU stock exchange, this Australia-based company holds position #23214 globally and #868 in its home market, demonstrating a -3.41% decrease in market value over the past year.
Market capitalization, also known as net worth in stock markets, is calculated by multiplying Pharmx Technologies Ltd's stock price AU$0.09 by its total outstanding shares 599506789 (599.51 Million). Also see how large is Pharmx Technologies Ltd's balance sheet for a full breakdown of the balance sheet.
Pharmx Technologies Ltd Market Cap History: 2015 to 2026
Pharmx Technologies Ltd's market capitalization history from 2015 to 2026. Data shows change from $43.39 Million to $36.06 Million (-1.68% CAGR). Also see Pharmx Technologies Ltd (PHX) cash flow conversion for how efficiently the company converts equity into cash flow.
Pharmx Technologies Ltd Market Cap to Earnings & Revenue Ratios Timeline
This chart shows how Pharmx Technologies Ltd's valuation ratios have evolved. The Price to Sales (P/S) ratio compares market cap to revenue, while the Price to Earnings (P/E) ratio compares market cap to net income. Lower values may indicate a more undervalued company relative to its financial performance. Check Pharmx Technologies Ltd (PHX) stock price for real-time trading data and today's change.
Latest Price to Sales (P/S) Ratio
9.27x
Pharmx Technologies Ltd's market cap is 9.27 times its annual revenue
Latest Price to Earnings (P/E) Ratio
N/A
P/E ratio not applicable due to negative or zero earnings
What These Ratios Tell Investors:
- Price to Sales (P/S) Ratio: Shows how much investors are paying for each dollar of the company's sales. Lower P/S ratios may indicate undervaluation.
- Price to Earnings (P/E) Ratio: Shows how much investors are paying for each dollar of the company's earnings. This is one of the most common valuation metrics.
- Trends in these ratios over time can indicate changing investor sentiment about the company's future growth prospects.
- Industry comparison provides context for whether the company is valued higher or lower than peers.
| Year | Market Cap (USD) | Revenue (USD) | Net Income (USD) | P/S Ratio | P/E Ratio |
|---|---|---|---|---|---|
| 2016 | $21.68 Million | $15.55 Million | $27.00K | 1.39x | 802.82x |
| 2017 | $13.02 Million | $13.51 Million | -$5.88 Million | 0.96x | N/A |
| 2018 | $10.35 Million | $11.18 Million | $251.00K | 0.93x | 41.24x |
| 2019 | $27.02 Million | $10.13 Million | -$4.21 Million | 2.67x | N/A |
| 2020 | $32.37 Million | $9.12 Million | $176.00K | 3.55x | 183.90x |
| 2021 | $21.80 Million | $12.70 Million | $1.09 Million | 1.72x | 19.98x |
| 2022 | $10.90 Million | $11.92 Million | $252.00K | 0.91x | 43.26x |
| 2023 | $17.39 Million | $6.02 Million | -$1.05 Million | 2.89x | N/A |
| 2024 | $31.39 Million | $6.49 Million | -$1.77 Million | 4.84x | N/A |
| 2025 | $67.87 Million | $7.32 Million | -$264.00K | 9.27x | N/A |
Competitor Companies of PHX by Market Capitalization
Companies near Pharmx Technologies Ltd in the global market cap rankings as of September 17, 2026. Review Pharmx Technologies Ltd tangible net worth ratio to assess the quality of the company's equity after excluding intangible assets.
Key companies related to Pharmx Technologies Ltd by market ranking:
- Veeva Systems Inc Class A (NYSE:VEEV): Ranked #738 globally with a market cap of $37.44 Billion USD.
- Pro Medicus Ltd (AU:PME): Ranked #1902 globally with a market cap of $12.23 Billion USD ( AU$17.28 Billion AUD).
- Tempus AI, Inc. Class A Common Stock (NASDAQ:TEM): Ranked #2076 globally with a market cap of $11.06 Billion USD.
- BrightSpring Health Services, Inc. Common Stock (NASDAQ:BTSG): Ranked #2133 globally with a market cap of $10.63 Billion USD.
| Rank | Company | Symbol | Market Cap | Price |
|---|---|---|---|---|
| #738 | Veeva Systems Inc Class A | NYSE:VEEV | $37.44 Billion | $266.62 |
| #1902 | Pro Medicus Ltd | AU:PME | $12.23 Billion | AU$165.45 |
| #2076 | Tempus AI, Inc. Class A Common Stock | NASDAQ:TEM | $11.06 Billion | $68.85 |
| #2133 | BrightSpring Health Services, Inc. Common Stock | NASDAQ:BTSG | $10.63 Billion | $58.84 |
Pharmx Technologies Ltd Historical Marketcap From 2015 to 2026
Between 2015 and today, Pharmx Technologies Ltd's market cap moved from $43.39 Million to $ 36.06 Million, with a yearly change of -1.68%.
| Year | Market Cap | Change (%) |
|---|---|---|
| 2026 | AU$36.06 Million | -46.88% |
| 2025 | AU$67.87 Million | +116.22% |
| 2024 | AU$31.39 Million | +80.49% |
| 2023 | AU$17.39 Million | +59.53% |
| 2022 | AU$10.90 Million | -50.00% |
| 2021 | AU$21.80 Million | -32.63% |
| 2020 | AU$32.37 Million | +19.78% |
| 2019 | AU$27.02 Million | +161.07% |
| 2018 | AU$10.35 Million | -20.52% |
| 2017 | AU$13.02 Million | -39.92% |
| 2016 | AU$21.68 Million | -50.05% |
| 2015 | AU$43.39 Million | -- |
End of Day Market Cap According to Different Sources
On Sep 16th, 2026 the market cap of Pharmx Technologies Ltd was reported to be:
| Source | Market Cap |
|---|---|
| Yahoo Finance | $36.06 Million USD |
| MoneyControl | $36.06 Million USD |
| MarketWatch | $36.06 Million USD |
| marketcap.company | $36.06 Million USD |
| Reuters | $36.06 Million USD |
Market cap values may vary slightly between sources due to differences in calculation methods, timing, and data refresh rates.
About Pharmx Technologies Ltd
PharmX Technologies Limited, together with its subsidiaries, operates as a technology and software development company in Australia. It also operates PharmX, an electronic ordering and invoicing gateway; PharmX Marketplace, an e-commerce ordering platform; PharmX Analytics which provides insights for operations of supplier and pharmacy customers. The company was formerly known as Corum Group Limi… Read more